| Structures of human acetylcholinesterase in complex with pharmacologically important ligands J Cheung, MJ Rudolph, F Burshteyn, MS Cassidy, EN Gary, J Love, ... Journal of medicinal chemistry 55 (22), 10282-10286, 2012 | 1105 | 2012 |
| Immunogenicity of a DNA vaccine candidate for COVID-19 TRF Smith, A Patel, S Ramos, D Elwood, X Zhu, J Yan, EN Gary, ... Nature communications 11 (1), 2601, 2020 | 655 | 2020 |
| Structures of human acetylcholinesterase bound to dihydrotanshinone I and territrem B show peripheral site flexibility J Cheung, EN Gary, K Shiomi, TL Rosenberry ACS medicinal chemistry letters 4 (11), 1091-1096, 2013 | 242 | 2013 |
| DNA vaccines: prime time is now EN Gary, DB Weiner Current Opinion in Immunology 65, 21-27, 2020 | 157 | 2020 |
| Structural genomics for drug design against the pathogen Coxiella burnetii MC Franklin, J Cheung, MJ Rudolph, F Burshteyn, M Cassidy, E Gary, ... Proteins: Structure, Function, and Bioinformatics 83 (12), 2124-2136, 2015 | 88 | 2015 |
| Intradermal-delivered DNA vaccine provides anamnestic protection in a rhesus macaque SARS-CoV-2 challenge model A Patel, J Walters, EL Reuschel, K Schultheis, E Parzych, EN Gary, ... BioRxiv, 2020.07. 28.225649, 2020 | 67 | 2020 |
| SARS-CoV-2 assays to detect functional antibody responses that block ACE2 recognition in vaccinated animals and infected patients SN Walker, N Chokkalingam, EL Reuschel, M Purwar, Z Xu, EN Gary, ... Journal of Clinical Microbiology 58 (11), 10.1128/jcm. 01533-20, 2020 | 59 | 2020 |
| Debulking SARS-CoV-2 in saliva using angiotensin converting enzyme 2 in chewing gum to decrease oral virus transmission and infection H Daniell, SK Nair, N Esmaeili, G Wakade, N Shahid, PK Ganesan, ... Molecular Therapy 30 (5), 1966-1978, 2022 | 49 | 2022 |
| Crystal structures of ricin toxin's enzymatic subunit (RTA) in complex with neutralizing and non-neutralizing single-chain antibodies MJ Rudolph, DJ Vance, J Cheung, MC Franklin, F Burshteyn, MS Cassidy, ... Journal of molecular biology 426 (17), 3057-3068, 2014 | 41 | 2014 |
| Intradermal-delivered DNA vaccine induces durable immunity mediating a reduction in viral load in a rhesus macaque SARS-CoV-2 challenge model A Patel, JN Walters, EL Reuschel, K Schultheis, E Parzych, EN Gary, ... Cell Reports Medicine 2 (10), 2021 | 19 | 2021 |
| Adenosine deaminase-1 enhances germinal center formation and functional antibody responses to HIV-1 Envelope DNA and protein vaccines E Gary, M O'connor, M Chakhtoura, V Tardif, OK Kumova, DC Malherbe, ... Vaccine 38 (22), 3821-3831, 2020 | 18 | 2020 |
| Structure of the Chikungunya virus nsP2 protease J Cheung, M Franklin, F Mancia, M Rudolph, M Cassidy, E Gary, ... Unpublished work, 2011 | 17 | 2011 |
| DNA-delivered antibody cocktail exhibits improved pharmacokinetics and confers prophylactic protection against SARS-CoV-2 EM Parzych, J Du, AR Ali, K Schultheis, D Frase, TRF Smith, J Cui, ... Nature Communications 13 (1), 5886, 2022 | 16 | 2022 |
| Prime-boost vaccination regimens with INO-4800 and INO-4802 augment and broaden immune responses against SARS-CoV-2 in nonhuman primates JN Walters, B Schouest, A Patel, EL Reuschel, K Schultheis, E Parzych, ... Vaccine 40 (21), 2960-2969, 2022 | 12 | 2022 |
| A novel mouse AAV6 hACE2 transduction model of wild-type SARS-CoV-2 infection studied using synDNA immunogens EN Gary, BM Warner, EM Parzych, BD Griffin, X Zhu, N Tailor, NJ Tursi, ... iscience 24 (7), 2021 | 12 | 2021 |
| Mucosal chemokine adjuvant enhances synDNA vaccine-mediated responses to SARS-CoV-2 and provides heterologous protection in vivo EN Gary, NJ Tursi, B Warner, EM Parzych, AR Ali, D Frase, E Moffat, ... Cell Reports Medicine 3 (7), 2022 | 9 | 2022 |
| Bifunctional Chimera That Coordinately Targets Human Immunodeficiency Virus 1 Envelope gp120 and the Host-Cell CCR5 Coreceptor at the Virus–Cell Interface AA Rashad, LR Song, AP Holmes, K Acharya, S Zhang, ZL Wang, E Gary, ... Journal of medicinal chemistry 61 (11), 5020-5033, 2018 | 9 | 2018 |
| CCR10 expression is required for the adjuvant activity of the mucosal chemokine CCL28 when delivered in the context of an HIV-1 Env DNA vaccine EN Gary, N Kathuria, G Makurumidze, A Curatola, A Ramamurthi, ... Vaccine 38 (11), 2626-2635, 2020 | 7 | 2020 |
| Rapid development of a synthetic DNA vaccine for COVID-19 TR Smith, A Patel, S Ramos, D Elwood, X Zhu, J Yan, M Yang, ... | 7 | 2020 |
| Defensive driving: directing HIV-1 vaccine-induced humoral immunity to the mucosa with chemokine adjuvants EN Gary, MA Kutzler Journal of immunology research 2018, 2018 | 7 | 2018 |
